And here’s the good news today. In late 2025, researchers from the Division of Allergy and Immunology at Children’s Hospital of Philadelphia reported that the prevalence of peanut allergies in ...

Helen Blythe has spent the last two years helping to shape the strategy after her son Benedict’s death. She said: “This is a ...

ANKTIVA approved for patients with certain indications of non-muscle invasive bladder cancer and non-small cell lung cancer -- Commercial availability achieved within two months of announcing MENA ...

New mRNA vaccines could be a critical tool to fight cancer. But their future is up in the air - More than 626,000 Americans ...

It's not just about gut health. How hitting your 30g daily fibre target can fight skin ageing, calm inflammation and more ...

Molluscum contagiosum, a common and highly contagious skin infection caused by a poxvirus, affects millions of individuals ...

Immunotherapy—particularly PD-1 inhibition with cemiplimab—is reshaping CSCC care by expanding into neoadjuvant and adjuvant ...

Healthcare sector performance reflects steady pharmaceutical and medical technology demand Financial results show revenue ...

Macrophages, key regulators of tissue health and immune defense, are among the most abundant immune cells in solid tumors. Their role in cancer has been difficult to define because even closely ...

The bispecific antibodies market presents growth opportunities in cancer, autoimmune, and inflammatory therapies, driven by robust clinical progress, technological innovation, and strategic ...

Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, ...